PNC Financial Services Group’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $188K | Sell |
|
|||||
|
2025
Q1 | $213K | Sell |
|
|||||
|
2024
Q4 | $225K | Buy |
|
|||||
|
2024
Q3 | $203K | Sell |
|
|||||
|
2024
Q2 | $172K | Sell |
|
|||||
|
2024
Q1 | $162K | Buy |
|
|||||
|
2023
Q4 | $131K | Buy |
|
|||||
|
2023
Q3 | $83.3K | Sell |
|
|||||
|
2023
Q2 | $111K | Sell |
|
|||||
|
2023
Q1 | $115K | Buy |
|
|||||
|
2022
Q4 | $95.9K | Sell |
|
|||||
|
2022
Q3 | $110K | Buy |
|
|||||
|
2022
Q2 | $78K | Sell |
|
|||||
|
2022
Q1 | $135K | Buy |
|
|||||
|
2021
Q4 | $175K | Buy |
|
|||||
|
2021
Q3 | $141K | Buy |
|
|||||
|
2021
Q2 | $84K | Sell |
|
|||||
|
2021
Q1 | $101K | Buy |
|
|||||
|
2020
Q4 | $60K | Sell |
|
|||||
|
2020
Q3 | $80K | Sell |
|
|||||
|
2020
Q2 | $105K | Sell |
|
|||||
|
2020
Q1 | $79K | Sell |
|
|||||
|
2019
Q4 | $129K | Buy |
|
|||||
|
2019
Q3 | $108K | Sell |
|
|||||
|
2019
Q2 | $254K | Buy |
|
|||||
|
2019
Q1 | $249K | Buy |
|
|||||
|
2018
Q4 | $263K | Sell |
|
|||||
|
2018
Q3 | $8.08M | Sell |
|
|||||
|
2018
Q2 | $8.2M | Buy |
|
|||||
|
2018
Q1 | $6.53M | Sell |
|
|||||
|
2017
Q4 | $5.44M | Buy |
|
|||||
|
2017
Q3 | $3.71M | Buy |
|
|||||
|
2017
Q2 | $1.21M | Buy |
|
|||||
|
2017
Q1 | $1M | Sell |
|
|||||
|
2016
Q4 | $1.4M | Sell |
|
|||||
|
2016
Q3 | $1.87M | Sell |
|
|||||
|
2016
Q2 | $2.23M | Buy |
|
|||||
|
2016
Q1 | $1.97M | Buy |
|
|||||
|
2015
Q4 | $1.37M | Buy |
|
|||||
|
2015
Q3 | $1.07M | Buy |
|
|||||
|
2015
Q2 | $1.23M | Buy |
|
|||||
|
2015
Q1 | $745K | Buy |
|
|||||
|
2014
Q4 | $392K | Sell |
|
|||||
|
2014
Q3 | $515K | Sell |
|
|||||
|
2014
Q2 | $862K | Sell |
|
|||||
|
2014
Q1 | $1M | Buy |
|
|||||
|
2013
Q4 | $697K | Sell |
|
|||||
|
2013
Q3 | $876K | Sell |
|
|||||
|
2013
Q2 | $876K | Buy |
|